Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia
Clinical trial NCT04010305 · COMPLETED
Trial details
- NCT number
- NCT04010305
- Sponsor
- BioXcel Therapeutics Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-22
- Primary completion
- 2019-07-31
- Enrollment
- 135
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.